-David R Hinton Researcher Activity Profile

Research Author Detailed Information 

David R Hinton Publication Rate By Year

David R Hinton has published 1 paper(s) in 1996, 2 paper(s) in 2006, 8 paper(s) in 2007, 5 paper(s) in 2008, for a total of 16 research publications in total.

David R Dr Hinton Author Information

LAST NAME: hinton

FIRST NAME: David R

INITIALS: dr

AFFILIATION:

Papers

David R Hinton's Publication Record

1. alpha-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress. Year Published: 2007
Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
2. Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative vitreoretinopathy. Year Published: 1996
Doheny Eye Institute, Los Angeles, CA 90033, USA.
3. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. Year Published: 2006
Department of Neurology, University of Southern California, Keck School of Medicine, Los Angeles, California, USA.
4. Malignant clival chordoma with postoperative cutaneous metastases. Year Published: 2006
5. Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease. Year Published: 2007
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
6. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Year Published: 2007
Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
7. Thrombospondin-1 expression in RPE and choroidal neovascular membranes. Year Published: 2007
Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles 90033, USA.
8. In vivo models of proliferative vitreoretinopathy. Year Published: 2007
Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
9. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. Year Published: 2007
The Cleveland Clinic, 2500 Euclid Avenue, NC30, Cleveland, OH 44195, USA.
10. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. Year Published: 2007
The Cleveland Clinic, 2500 Euclid Avenue, NC30, Cleveland, OH 44195, USA.
11. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. Year Published: 2008
Department of Neurosciences NC30, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. stohlms2@ccf.org
12. Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia. Year Published: 2008
Department of Pathology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90033, USA; Arnold and Mabel Beckman Macular Research Center, Los Angeles, CA 90033, USA.
13. In vivo models of proliferative vitreoretinopathy. Year Published: 2007
Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90033, USA.
14. N-(4-hydroxyphenyl) retinamide augments laser-induced choroidal neovascularization in mice. Year Published: 2008
The Arnold and Mabel Beckman Macular Research Center, Doheny Eye Institute, Childrens Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
15. Exacerbation of retinal degeneration in the absence of alpha crystallins in an in vivo model of chemically induced hypoxia. Year Published: 2008
Department of Pathology, Keck School of Medicine at the University of Southern California, Los Angeles, CA 90033, USA.
16. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. Year Published: 2008
Department of Neurosciences NC30, Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. stohlms2@ccf.org